{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-104998","form_type":"8-K","ticker":"RANI","cik":"0001856725","company_name":"Rani Therapeutics Holdings, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.397863+00:00","generated_at":"2026-05-17T18:20:55.159638+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Rani Therapeutics Q2 net loss $11.2M, cash at $10.2M; collaboration with Chugai announced","bullets":["Net loss of $11.2M for Q2 2025 vs $13.4M in Q2 2024; includes $3.3M stock-based compensation.","Cash, equivalents and marketable securities fell to $10.2M as of June 30, 2025 from $27.6M at Dec 31, 2024.","Entered research collaboration with Chugai for two undisclosed molecules; bioequivalence to subcutaneous delivery confirmed.","Warrant inducement transaction yielded $4.3M gross proceeds; registered direct offering raised $3.0M.","Phase 1 trial of oral GLP-1/GLP-2 agonist RT-114 for obesity expected to start H2 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-104998","json":"https://secwatch.observer/filing/0000950170-25-104998.json","markdown":"https://secwatch.observer/filing/0000950170-25-104998.md","text":"https://secwatch.observer/filing/0000950170-25-104998.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1856725/000095017025104998/0000950170-25-104998-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1856725/000095017025104998/rani-20250807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:20:55.159638+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}